» Articles » PMID: 36657981

Molecular Imaging of Pulmonary Inflammation in Users of Electronic and Combustible Cigarettes: A Pilot Study

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2023 Jan 19
PMID 36657981
Authors
Affiliations
Soon will be listed here.
Abstract

Electronic cigarette (EC) use has increased dramatically, particularly among adolescents and young adults, and, like cigarette use, can cause pulmonary inflammation and increase the risk of lung disease. This preliminary study used PET with F-6-(1/2)(2-fluoro-propyl)-4-methylpyridin-2-amine (F-NOS) to quantify inducible nitric oxide synthase expression to characterize oxidative stress and inflammation in the lungs in vivo in 3 age- and sex-matched groups: 5 EC users, 5 cigarette smokers, and 5 controls who had never smoked or vaped. EC users showed greater F-NOS nondisplaceable binding potential (BP) than cigarette smokers ( = 0.03) and controls ( = 0.01), whereas BP in cigarette smokers did not differ from that in controls ( > 0.1). F-NOS lung tissue delivery and inducible nitric oxide synthase distribution volume did not significantly differ among groups. Although there were no group differences in peripheral inflammatory biomarker concentrations, F-NOS BP correlated with the proinflammatory cytokine tumor necrosis factor-α concentrations ( = 0.87, = 0.05) in EC users. Additionally, when EC users and cigarette smokers were pooled together, number of vaping episodes or cigarettes per day correlated with interleukin-6 levels ( = 0.86, = 0.006). This is the first PET imaging study to compare lung inflammation between EC and cigarette users in vivo. We found preliminary evidence that EC users have greater pulmonary inflammation than cigarette smokers and controls, with a positive association between pulmonary and peripheral measures of inflammation.

Citing Articles

Current perspective on e-cigarette use and respiratory outcomes: mechanisms and messaging.

Wills T, Maziak W, Asfar T, Roy S Expert Rev Respir Med. 2024; 18(8):597-609.

PMID: 39101843 PMC: 11405137. DOI: 10.1080/17476348.2024.2387090.


Imaging neuroinflammation in individuals with substance use disorders.

Li X, Ramos-Rolon A, Kass G, Pereira-Rufino L, Shifman N, Shi Z J Clin Invest. 2024; 134(11).

PMID: 38828729 PMC: 11142750. DOI: 10.1172/JCI172884.


Review of quantitative and functional lung imaging evidence of vaping-related lung injury.

Hofmann J, Poulos V, Zhou J, Sharma M, Parraga G, McIntosh M Front Med (Lausanne). 2024; 11:1285361.

PMID: 38327710 PMC: 10847544. DOI: 10.3389/fmed.2024.1285361.


Alcohol and e-cigarette damage alveolar-epithelial barrier by activation of P2X7r and provoke brain endothelial injury via extracellular vesicles.

Mekala N, Trivedi J, Bhoj P, Togre N, Rom S, Sriram U Cell Commun Signal. 2024; 22(1):39.

PMID: 38225580 PMC: 10789007. DOI: 10.1186/s12964-023-01461-1.


Alcohol and e-cigarette damage alveolar-epithelial barrier by activation of P2X7r and provoke brain endothelial injury via extracellular vesicles.

Mekala N, Trivedi J, Bhoj P, Togre N, Rom S, Sriram U Res Sq. 2023; .

PMID: 38014253 PMC: 10680944. DOI: 10.21203/rs.3.rs-3552555/v1.


References
1.
Fagerstrom K . Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. 2011; 14(1):75-8. DOI: 10.1093/ntr/ntr137. View

2.
Koch A, Burgschweiger A, Herpel E, Sack F, Schirmacher P, Szabo G . Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course. Eur J Cardiothorac Surg. 2007; 32(4):639-43. DOI: 10.1016/j.ejcts.2007.06.041. View

3.
Khanna A, Guo M, Mehra M, Royal 3rd W . Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol. 2012; 254(1-2):69-75. PMC: 3534934. DOI: 10.1016/j.jneuroim.2012.09.006. View

4.
Zhou D, Lee H, Rothfuss J, Chen D, Ponde D, Welch M . Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase. J Med Chem. 2009; 52(8):2443-53. PMC: 2782628. DOI: 10.1021/jm801556h. View

5.
Branley H, du Bois R, Wells A, Jones H . Peripheral-type benzodiazepine receptors in bronchoalveolar lavage cells of patients with interstitial lung disease. Nucl Med Biol. 2007; 34(5):553-8. DOI: 10.1016/j.nucmedbio.2007.03.005. View